eISSN: 2450-4459
ISSN: 2450-3517
Lekarz POZ
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
5/2018
vol. 4
 
Share:
Share:
more
 
 
abstract:
Review paper

Proper diagnosis of chronic obstructive pulmonary disease and personalised treatment

Tadeusz Płusa

Online publish date: 2018/11/30
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
In the treatment of chronic diseases, the principle of reaching the goal or “treat to target” is assumed. It is possible if the diagnosis of the disease is appropriate, based on contemporary criteria. The second condition in the effective implementation of the goal is to have appropriate drugs that can reach the most peripheral airways. The inflammatory process in the course of chronic obstructive pulmonary disease (COPD) takes place in small bronchi, which not all inhaled drugs can reach. In addition, the diagnosis of COPD – eosinophilic or neutrophilic endotype – is important in the choice of treatment. In the eosinophilic endotype, patients with COPD respond well to inhaled glucocorticoids, while in the neutrophilic endotype there is a better response to administered preparations of long-acting muscarinic agonists (LAMA). Treatment with benralizumab and mepolizumab in patients with COPD with high eosinophilia significantly reduced the number of exacerbations. New therapeutic options require a precise diagnosis of the disease in order to personalise the treatment according to the endotype and phenotype.
keywords:

COPD, endotypes, eosinophilia, small bronchi, treatment

Quick links
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe